Hepatitis C virus (HCV) genotype change after treatment with interferon alpha 2B (INF-alpha 2b).

被引：0
|
作者：
PerezJimenez, O
Kapur, J
Szentendrei, T
Bednarek, J
Sjogren, MH
机构：
[1] ARMED FORCES INST PATHOL,WASHINGTON,DC 20306
[2] WALTER REED ARMY MED CTR,WASHINGTON,DC 20307
来源：
HEPATOLOGY | 1996年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1738 / 1738
页数：1
相关论文
共 50 条
  • [1] Pegylated interferon alpha 2b induces less thyroid dysfunction than standard interferon alpha 2b in the treatment of chronic hepatitis C
    Patel, Y
    Chapalamadugu, R
    Ramdhaney, S
    Baradarian, R
    Iswara, K
    Tenner, S
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S87 - S88
  • [2] Treatment of chronic hepatitis C with recombinant alpha 2b interferon.
    Lopez, F
    Rizo, MT
    Ysita, A
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A1241 - A1241
  • [3] Interferon Alpha 2b in Combination with Ribavirin as a Treatment for Chronic Hepatitis C
    Mandokhel, Sherbet Khan
    Aziz-U-Rehman
    Khan, Mohammad Saleem
    Azeemullah
    [J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (01): : 168 - 171
  • [4] Renal failure after treatment with interferon alpha 2b
    Roeloffzen, WWH
    Hospers, GAP
    De Vries, EGE
    Navis, GJ
    [J]. ANTICANCER RESEARCH, 2002, 22 (03) : 1929 - 1931
  • [5] Development of latent Interferon alpha 2b as a safe therapeutic for treatment of Hepatitis C virus infection
    Iram Gull
    Muhammad Shahbaz Aslam
    Imran Tipu
    Roohi Mushtaq
    Tehseen Zamir Ali
    Muhammad Amin Athar
    [J]. Scientific Reports, 9
  • [6] Development of latent Interferon alpha 2b as a safe therapeutic for treatment of Hepatitis C virus infection
    Gull, Iram
    Aslam, Muhammad Shahbaz
    Tipu, Imran
    Mushtaq, Roohi
    Ali, Tehseen Zamir
    Athar, Muhammad Amin
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [7] Response to interferon alpha 2B plus ribavirin in hepatitis C infected patients who failed interferon alpha 2B monotherapy.
    King, JW
    Favrot, DR
    Shakhashiro, A
    Gholson, CF
    Balart, LA
    Achord, J
    Kirkikis, JA
    Lyles, WE
    Hollier, JD
    Srinivas, D
    [J]. HEPATOLOGY, 1998, 28 (04) : 708A - 708A
  • [8] Intermediate dose interferon alpha 2b (IFN alpha 2b) in adiuvant treatment for Malignant Melanoma
    Savio, G.
    Calabria, C.
    Leonardi, V.
    Laudani, A.
    Pepe, A.
    Blasi, L.
    Usset, A.
    Rondello, G.
    Agostara, B.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 171 - 171
  • [9] RAPID NEUROLOGIC DECLINE IN AN MS PATIENT TREATED WITH SYSTEMIC INTERLEUKIN 2(IL-2) AND INTERFERON-ALPHA (INF-ALPHA 2B)
    KINKEL, RP
    RUDICK, RA
    [J]. NEUROLOGY, 1994, 44 (04) : A392 - A393
  • [10] DIFFERENTIAL EFFECT OF PEGYLATED INTERFERON alpha 2a AND alpha 2b ON THE EARLY HEPATITIS C VIRUS KINETICS
    Durante-Mangoni, E.
    Pinto, D.
    Battimelli, C.
    Farinaro, V.
    Savinelli, C.
    Senese, A.
    Iorio, V.
    Graziano, C.
    Iossa, D.
    Molaro, R.
    Sodano, G.
    Utili, R.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S333 - S333
12345